Cargando…
Drépanocytose en République Démocratique du Congo: quels sont les obstacles à un traitement par hydroxyurée?
INTRODUCTION: hydroxyurea is the unique medication that has been proven to prevent complications in patients with sickle cell disease and is approved by the Food and Drug Administration. This medication requires a prescription to be dispensed, it must be available and at an affordable price. The pur...
Autores principales: | Mukinayi, Benoît Mbiya, Cibeyibeyi, Guelord Kalombo, Tumba, Ghislain Disashi, Gulbis, Béatrice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017361/ https://www.ncbi.nlm.nih.gov/pubmed/33854670 http://dx.doi.org/10.11604/pamj.2021.38.41.18718 |
Ejemplares similares
-
Sickle Cell Disease in the Democratic Republic of Congo: Assessing Physicians’ Knowledge and Practices
por: Mukinayi Mbiya, Benoît, et al.
Publicado: (2020) -
Co-occurrence of sickle cell disease and oculocutaneous albinism in a Congolese patient: a case report
por: Mbiya Mukinayi, Benoît, et al.
Publicado: (2021) -
Connaissances et comportements de 50 familles congolaises concernées par la drépanocytose: une enquête locale
por: Mukinayi, Benoît Mbiya, et al.
Publicado: (2018) -
Improvement of SCD morbimortality in children: experience in a remote area of an African country
por: Mbiya, Benoît Mukinayi, et al.
Publicado: (2021) -
P-033: CLINICAL AND HEMATOLOGICAL FOLLOW UP OF SICKLE CELL DISEASE PATIENTS IN A REMOTE CITY IN A COUNTRY WITH LIMITED RESOURCES
por: B., MBIYA-MUKINAYI, et al.
Publicado: (2022)